FCN1 and acute respiratory distress syndrome: This finding strongly suggests that previous associations identified between early (Day 1 of ARDS) or late (Day 8) pro-inflammatory bulk alveolar myeloid gene expression signatures and clinical outcomes are driven primarily by Inflammatory or FCN1 monocyte subsets (rather than more mature alveolar macrophage subsets)41,52.